Results 91 to 100 of about 102,673 (134)

A Large‐Scale Retrospective Study of Serum Des‐Gamma‐Carboxy Prothrombin as a Diagnostic Marker of HCC: Effect of Liver Function on Specificity

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Serum DCP may serve as an optimal biomarker for the diagnosis of HCC, but its accuracy appears to be influenced by liver function. The serum DCP may also serve as a biomarker for liver resection and interventional therapy of HCC, but is not promising for systemic treatment. ABSTRACT Background This retrospective multicenter study is aimed at evaluating
Hongying Bu   +12 more
wiley   +1 more source

Vitamin D—A prominent immunomodulator to prevent COVID‐19 infection

open access: yesInternational Journal of Rheumatic Diseases, Volume 26, Issue 1, Page 13-30, January 2023., 2023
Abstract COVID‐19 remains a life‐threatening infectious disease worldwide. Several bio‐active agents have been tested and evaluated in an effort to contain this disease. Unfortunately, none of the therapies have been successful, owing to their safety concerns and the presence of various adverse effects.
Sumel Ashique   +13 more
wiley   +1 more source

Shining stars in the sky on the gastric mucosa

open access: yesJournal of General and Family Medicine, EarlyView.
We report a rare case of an elderly Japanese man diagnosed with sporadic gastric Burkitt lymphoma. Esophagogastroduodenoscopy showed nodular and ulcerated lesions in the lesser curvature of the stomach. Pathological analysis of showed that the gastric lesions are characterized by a diffuse and dense accumulation of dark atypical lymphocytes (night) and
Kosuke Minaga   +3 more
wiley   +1 more source

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

open access: yesThoracic Cancer, Volume 13, Issue 23, Page 3420-3430, December 2022., 2022
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Abstract Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment.
Wenxian Wang   +79 more
wiley   +1 more source

Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study

open access: yesActa Anaesthesiologica Scandinavica, Volume 67, Issue 1, Page 76-85, January 2023., 2023
Abstract Background Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID‐19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID‐19 in Denmark during the first and second waves of the pandemic.
Lene Russell   +28 more
wiley   +1 more source

Infections after liver transplantation: An analysis of 101 consecutive cases [PDF]

open access: yes, 1988
Esquivel, C   +8 more
core   +1 more source

Integrated gross and microanatomical analysis of the periportal lymphatic system in human liver

open access: yesJournal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Abstract Background Although animal studies have indicated that the periportal lymphatic system is an important intrahepatic lymphatic route, detailed human studies are scarce. We studied the lymphatic pathways and dynamics around Glisson's capsule in human livers. Methods We performed whole‐mount immunostaining for the liver using podoplanin and CD‐31
Yuto Mitsuhashi   +9 more
wiley   +1 more source

DNA damage contributes to age‐associated differences in SARS‐CoV‐2 infection

open access: yesAging Cell, Volume 21, Issue 12, December 2022., 2022
Our data suggest DNA damage contributes to age‐associated differences in SARS‐CoV‐2 infection and provide a novel target for anti‐viral intervention. Abstract Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is known to disproportionately affect older individuals.
Rui Jin   +14 more
wiley   +1 more source

Upadacitinib for difficult‐to‐treat paediatric Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy